Literature DB >> 7419008

Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease.

A E Bishop, J M Polak, M G Bryant, S R Bloom, S Hamilton.   

Abstract

The possible involvement of nerves containing vasoactive intestinal polypeptide in Crohn's disease was investigated by immunocytochemistry and radioimmunoassay of specimens from 17 patients with well-defined clinical and histologic features of the disease. The characteristic pattern of slender fibers, evenly distributed across the gut wall, was seen in specimens taken from controls, which consisted of (a) specimens from uninvolved areas of gut from carcinoma resection (n = 17) and (b) jejunoileal specimens obtained during bypass operation for obesity (n = 8) as well as in four of the six specimens from patients with ulcerative colitis. In contrast, this characteristic pattern was lost in all 17 patients with Crohn's disease, the pattern being replaced by thickened and more intensely immunostained fibers. These changes were consistently found in the mucosa and submucosa, and in 13 of the Crohn's disease cases, the abnormal pattern was totally transmural, involving both the myenteric and submucous plexus as well as the muscle layers. There was a > 200% increase in VIP content, as determined by radioimmunoassay, in Crohn's disease (294 +/- 29 pmol/g wet wt, mean +/- SEM) in comparison with (a) ulcerative colitis (93 +/- 5 pmol/g [P < 0.001]), and (b) controls consisting of carcinoma resection (108 +/- 39) and bypassed gut from obese patients (86 +/- 27 [P < 0.001]). At least part of the previously documented autonomic nerve changes in Crohn's disease are, thus, due to an increase in vasoactive intestinal polypeptide innervation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7419008

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  43 in total

1.  VIP immunoreactive nerves and somatostatin and serotonin containing cells in Crohn's disease.

Authors:  Shi-Jun Lu; Yu-Qing Liu; Jian-Shao Lin; Hong-Juan Wu; Yong-Hong Sun; Yu-Bin Tan
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

2.  Decreased colonic peptide histidine-methionine in idiopathic inflammatory bowel diseases.

Authors:  T R Koch; S R Michener; J A Carney; V L Go
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

3.  Influence of renovascular hypertension on the distribution of vasoactive intestinal peptide in the stomach and heart of rats.

Authors:  Irena Kasacka; Żaneta Piotrowska; Izabela Janiuk
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-19

Review 4.  Mast cell polymorphisms. Present concepts, future directions.

Authors:  D Befus; H Fujimaki; T D Lee; M Swieter
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

5.  Neuropeptides and nerve growth in inflammatory bowel diseases: a quantitative immunohistochemical study.

Authors:  C M Y Lee; R K Kumar; D Z Lubowski; E Burcher
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

6.  Peptide YY concentrations in normal ileum and colon and in idiopathic inflammatory bowel disease.

Authors:  T R Koch; D R Roddy; J A Carney; V L Go
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

7.  Sympathetic hyperactivity in patients with ulcerative colitis.

Authors:  Simona Maule; Giulia Pierangeli; Sabina Cevoli; Daniela Grimaldi; Paolo Gionchetti; Giovanni Barbara; Fernando Rizzello; Vincenzo Stanghellini; Roberto Corinaldesi; Massimo Campieri; Pietro Cortelli
Journal:  Clin Auton Res       Date:  2007-06-15       Impact factor: 4.435

8.  Isolated hepatic granulomas from mice infected with Schistosoma mansoni contain nerve growth factor.

Authors:  G W Varilek; J V Weinstock; N J Pantazis
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

9.  Organelle pathology in ulcerative and Crohn's colitis with special reference to the lysosomal alterations.

Authors:  C O'Morain; P Smethurst; A J Levi; T J Peters
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

10.  Gastrointestinal regulatory peptide storage granule abnormalities in jejunal mucosal diseases.

Authors:  J Dawson; M G Bryant; S R Bloom; T J Peters
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.